{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T09:46:54Z","timestamp":1720432014936},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.steroids.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T08:35:48Z","timestamp":1408869348000},"page":"108-112","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PA","title":["Is there a role for estrogen activity assays? Recombinant cell bioassay for estrogen: Development and applications"],"prefix":"10.1016","volume":"99","author":[{"given":"Karen Oerter","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.08.004_b0075","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1172\/JCI117616","article-title":"Estrogen levels in childhood determined by an ultra-sensitive recombinant cell bioassay","volume":"94","author":"Oerter","year":"1994","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.steroids.2014.08.004_b0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1203\/00006450-197311000-00006","article-title":"Plasma estrogens in childhood and puberty under physiologic and pathologic conditions","volume":"7","author":"Bidlingmaier","year":"1973","journal-title":"Pediatr Res"},{"key":"10.1016\/j.steroids.2014.08.004_b0015","first-page":"3203","article-title":"A longitudinal assessment of hormonal and physical alterations during normal puberty in boys II. Estrogen levels as determined by an ultrasensitive bioassay","volume":"81","author":"Klein","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.004_b0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0022-3476(99)70414-2","article-title":"Estrogen levels in girls with premature thelarche compared to normal prepubertal girls as determined by an ultrasensitive recombinant cell bioassay","volume":"134","author":"Klein","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.steroids.2014.08.004_b0025","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1210\/jcem.83.7.4929","article-title":"Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with an LHRH agonist","volume":"83","author":"Klein","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.004_b0030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1515\/JPEM.2007.20.11.1189","article-title":"LH and Estradiol suppression and growth in girls with central precocious puberty: Is more suppression better?","volume":"20","author":"Kunz","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.004_b0035","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1515\/JPEM.2004.17.12.1597","article-title":"An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys","volume":"17","author":"Mauras","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.004_b0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/JPEM.2003.16.1.91","article-title":"Estradiol levels in girls with Turner syndrome compared to normal prepubertal girls as determined by an ultrasensitive assay","volume":"16","author":"Wilson","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.steroids.2014.08.004_b0085","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1210\/jc.2011-1449","article-title":"Pharmacokinetics and pharmacodynamics of oral and transdermal 17\u03b2 estradiol in girls with Turner syndrome","volume":"96","author":"Taboada","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.004_b0050","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1210\/jc.2012-4243","article-title":"Metabolic effects of oral vs. transdermal 17-beta estradiol (E2): a randomized clinical trial in girls with Turner syndrome","volume":"98","author":"Torres-Santiago","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.004_b0090","first-page":"2658","article-title":"Use of ultra-sensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole","volume":"80","author":"Oerter","year":"1995","journal-title":"J Clinical Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2014.08.004_b0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042192-200205000-00006","article-title":"Treatment of urogenital atrophy with low-dose estradiol: preliminary results","volume":"9","author":"Santen","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2014.08.004_b0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/09513590009167711","article-title":"Estradiol suppression and recovery during leuprolide acetate treatment in women as determined weekly by an ultrasensitive recombinant cell bioassay","volume":"14","author":"Larmore","year":"2000","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.steroids.2014.08.004_b0070","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1210\/jc.2003-030349","article-title":"Estrogen bio-activity in Fo-Ti and other herbs used for their estrogen-like effects as determined by a recombinant cell bioassay","volume":"88","author":"Klein","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14001974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14001974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T05:53:21Z","timestamp":1538286801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14001974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":14,"alternative-id":["S0039128X14001974"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.08.004","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a role for estrogen activity assays? Recombinant cell bioassay for estrogen: Development and applications","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}